# 10% Lidocaine Spray for Intrauterine Device Insertion

> **NCT03870711** · PHASE4 · COMPLETED · sponsor: **Mahidol University** · enrollment: 124 (actual)

## Conditions studied

- Contraception
- Intrauterine Device

## Interventions

- **DRUG:** lidocaine spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03870711
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2019-12-17
- **Final completion:** 2019-12-17
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2020-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03870711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03870711, "10% Lidocaine Spray for Intrauterine Device Insertion". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03870711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*